Belépés

NCT05938673Befejeződött

Effects of rTSMS Associated With Treadmill Training in Patients With Parkinson's Disease

Effects of Repetitive Trans Spinal Magnetic Stimulation Associated With Treadmill Gait Training on Gait Disorders in Patients With Parkinson's Disease

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. márc. 2.

Rövid összefoglaló (regiszter, angolul)

Gait changes appear and become the main cause of disability, loss of independence, falls, fractures and reduced quality of life for patients with Parkinson Disease. Optimal gait management is complex and challenging. Some characteristics, such as gait variability, postural instability, and postural changes, continue to worsen over time despite optimal dopaminergic treatment, suggesting that additional interventions are needed. Given the physiology of gait and postural control in humans, spinal cord stimulation is a potential target for neuromodulatory approaches to gait and postural disorders. Repetitive transspinal magnetic stimulation ( rTSMS) has attracted a lot of attention, due to the possibility of modulating motor and sensory networks in a non-invasive way, activating directly the dorsal ascending pathways and projecting to the thalamic nuclei, cerebral cortex, and brainstem nuclei, thus stimulating descending motor tracts and interrupting aberrant oscillatory activity in corticobasal nuclei circuits. The combination of non-invasive neuromodulation with other therapies can enhance the effectiveness of rehabilitation, increasing plasticity and clinical efficacy, offering a greater and more sustained effect than either therapy alone.It's recommended that patients with PD perform a specific exercise for walking, such as treadmill training (tt), that imposes an external rhythm and concentration of attention on gait, acting as an external cue or marker, promoting a more stable gait, reducing gait variability and decreasing risk of falls. It is proposed, in this study, to develop a new treatment model through the integration of two promising and complementary approaches to improve gait disorders in PD: rTSMS and tt. Thus, the investigators idealized the realization of the first randomized, double-blind, placebo-controlled, parallel, phase III clinical trial that will evaluate the efficacy of tt associated with rTSMS in patients with PD.

Állapot (regiszter)
Befejeződött
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
76 (tényleges)
Első benyújtás
2023. jún. 2.
Kezdés
2023. jún. 1.
Elsődleges befejezés
2023. jún. 1.
Fő szponzor
University of Sao Paulo General Hospital
Betegségek
Parkinson-kór
NCT-szám
NCT05938673

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó
  • Bevont résztvevők: 76
  • 2023. jún. 1. és az elsődleges befejezés (2023. jún. 1.) között
  • 1 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Korábbi kezelés

  • Individuals with labyrinthine problems, using medication that may interfere with balance and performance in tests and treadmill training will be excluded.
  • Individuals who have undergone deep brain stimulation surgery or epidural spinal cord stimulation will be excluded.
  • Concomitant treatment with other experimental drugs;

Más betegség

  • Patients with unstabilized psychiatric comorbidities;
  • Individuals who have other neurological disorders, musculoskeletal, orthopedic, cardiovascular and respiratory disorders that may affect the ability to walk on the treadmill will be excluded.
  • Patients with uncontrolled infection or other uncontrolled pre-existing medical conditions (eg uncontrolled diabetes, high blood pressure, symptomatic lung or heart disease);
  • Patients with metal implants and a cardiac pacemaker.
  • Patient with a history of neurosurgery.

Egyéb

  • Pregnant or breastfeeding women.
  • Presence of chronic low back and lower limb pain.
  • Patients who cannot walk without assistance (cane, crutch, walker) or help from another person.

Kiket keres a vizsgálat

  • Men and women over the age of 18;
  • Participants with PD at Hoehn Yahr stages between 2 and 4 (moderate disease) while on-medication (i.e., at the time when their usual dopaminergic medication is clinically effective), whose primary symptom includes gait disturbance (score equal to or greater than 1 in subitem 2.12 of the MSD-UPDRS scale). Patients will be evaluated for the presence of freezing gait (freezing) through the Freezing of Gait Score (FOG-SCORE).
  • While on on-medication, be able to walk independently for 30 meters or with a unilateral assistive device.
  • Mini Mental State Examination (MMSE) score greater than or equal to 23.
  • Sign the informed consent form.

Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (1)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Hospital das Clinicas da Faculdade de Medicina da USP
Ennek a helyszínnek vagy a koordinátora? Erősítsd meg az állapotát
São PauloBrazíliaIsmeretlen állapot

Kapcsolódó publikációk

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.